At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 14 enrolled
Drug / intervention
Vivitrol (Medication Therapy) +1 moredrug
Likely dose
Vivitrol (Medication Therapy) 380 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders-a Pilot Study
Pacific Institute for Research and Evaluation·interventional·Posted Oct 1, 2007·Updated Aug 27, 2012
In Brief
A Phase 4 clinical trial evaluating Vivitrol (Medication Therapy) and Medication Management Therapy for Alcohol Consumption. Completed, enrolled 14 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether Vivitrol is effective at reducing attempts to drive after drinking among repeat driving while intoxicated (DWI) offenders with Ignition Interlock devices.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Consumption
CountriesUnited States
CollaboratorsCephalon
Timeline
Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2007
First PostedOct 2007
Primary CompletionMay 2009
TodayJul 2026
First PostedOct 1, 2007
Enrollment StartApr 1, 2007
Primary CompletionMay 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 18.8 years ago
Interventions
Vivitrol (Medication Therapy)drug
Vivitrol 380 mg/monthly
Medication Management Therapyother
Medication Management Therapy once a month.